Stanford University
Showing 8,901-8,950 of 37,036 Results
-
Ashley Fabrizio
Lecturer
BioAshley Fabrizio is a political scientist and quantitative researcher with experience answering descriptive and inferential questions in technology, academic, and government sectors using observational, survey, and data science methods. She is an expert in global issues of political mobilization, coercive governance, nationalism, human rights, and radicalization. Before joining More in Common, Ashley was a senior quantitative researcher at Meta. She received her M.A. and Ph.D. from Stanford University and B.A. from Harvard College.
-
Raj Fadadu
Casual - Non-Exempt, Epidemiology and Population Health
BioRaj Fadadu is currently a dermatology resident physician at the University of California, San Diego. He has experience conducting epidemiology research projects, particularly related to environmental exposures and skin diseases (e.g., atopic dermatitis and psoriasis) as well as epigenetics (e.g., EWAS and epigenetic age acceleration). At Stanford, his research in Dr. Andres Cardenas's group focuses on the relationship between environmental exposures and epigenetic modifications. He also held leadership roles in local and national organizations involved in climate change advocacy and education, working to improve community and patient health. In addition, he is a strong advocate for health equity and increasing access to medical care for people experiencing homelessness and has implemented innovative projects to do so while serving as an Albert Schweitzer Fellow and Director of student-run free clinics in Berkeley, CA. For his impactful work, he was named an Environmental Education "30 Under 30" in 2022 and received the Excellence in Climate Leadership Award from the American Public Health Association in 2022 and Emerging Physician Leader Award from Health Care Without Harm in 2021.
He received a M.D. from UC San Francisco, M.S. degree in Health and Medical Sciences (with concentrations in Environmental Research and Healthcare Management) from the UC Berkeley School of Public Health, and received a B.A. degree in Public Health from UC Berkeley (graduated with Highest Distinction and Research Honors). -
Marcel Fafchamps
Senior Fellow at the Freeman Spogli Institute for International Studies, Emeritus
Current Research and Scholarly InterestsSee my personal website for all my recent working papers.
-
Marc Fagel
Lecturer, Law Teaching
BioMarc Fagel spent nearly 30 years as a Bay Area securities litigator with a focus on Securities and Exchange Commission (SEC) enforcement. After six years as an associate at Morrison & Foerster, Marc joined the SEC’s San Francisco Regional Office as an enforcement staff attorney, investigating matters including insider trading, public company financial fraud, and misconduct by investment professionals. Marc later became the office’s Head of Enforcement and, from 2008-2013, served as Regional Director, overseeing the SEC’s enforcement and inspection programs throughout Northern California and the Pacific Northwest and managing the office’s staff of over 100 professionals.
After nearly 16 years with the SEC, Marc joined Gibson Dunn as a partner in the firm’s San Francisco and Palo Alto Offices, where he served as Co-Chair of the firm’s national Securities Enforcement practice group. Marc’s practice focused on representing public companies and their officers and directors, as well as financial institutions and investment managers, in investigations by the SEC, the Department of Justice, and other state and federal regulatory authorities.
In 2019, Marc retired from the full-time practice of law, and has since dedicated himself to writing and volunteer activities. Marc is currently a member of the Board of Directors of the Giffords Law Center to Prevent Gun Violence and the Board of Advisors of VoteRiders, a non-partisan organization dedicated to helping voters secure ID required by increasingly draconian voter ID requirements. He volunteers with local food banks, and has served as an election monitor for recent state and national elections.
Marc received his undergraduate degree from Princeton University and graduated with honors from the University of Chicago Law School. -
Norah Fahim
Advanced Lecturer
Current Research and Scholarly InterestsSPECIALIZATION: Digital Rhetoric, Narrative Inquiry, Writing Program Administration, Teaching English to Speakers of Other Languages, and Second Language Writing
-
Muneeb A. Faiq
Basic Life Research Scientist, Ophthalmology Research/Clinical Trials
BioDr. Muneeb A. Faiq is a behavioral and metabolic neuroscientist and ophthalmology researcher whose work spans molecular biology, neuroimaging, and systems neuroscience. He has made several foundational contributions, including the first functional cloning of CYP1B1 in congenital glaucoma, implicating retinoic-acid signaling in Zika virus–associated microcephaly, identifying central insulin resistance as a mechanistic basis for glaucoma, and providing the first in vivo evidence for a glymphatic pathway in the optic nerve. With more than 100 peer-reviewed publications and over 4,000 citations, Dr. Faiq has earned international recognition, including the Emerging Vision Scientist Award – 2019 from the Alliance for Eye and Vision Research. He is widely regarded as the pioneer and principal architect of the discipline of psychosomatic ophthalmology, a field he helped conceptualize and establish, leading to the integration of ophthalmic clinical practice with mindfulness-based and psychosomatic medicine frameworks. Dr. Faiq is currently advancing the concept of neurometabolic syntax in vision and brain function — a unifying systems-level framework that integrates genetics, metabolism, and behavior to reconceptualize ophthalmic and neurological diseases through a mechanistic and interdisciplinary lens. He has been selected for the prestigious Asia Pacific Academy of Ophthalmology (APAO) Achievement Award 2026.
-
Robert Michael Fairchild
Assistant Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDr. Fairchild’s research focuses on musculoskeletal and organ-based ultrasound in rheumatic disease, including arthritis, calcinosis, vascular pathology, and interstitial lung disease. He develops ultrasound-based outcome measures and leads projects applying deep learning and explainable AI to imaging. He also performs ultrasound-guided synovial biopsies to support translational and clinical research.
-
Jess Fairlie
Ph.D. Student in Civil and Environmental Engineering, admitted Winter 2026
BioJess Fairlie is a PhD student in the Baker lab, studying cross-shore sediment transport under infragravity waves. Jess completed her BS in Environmental Systems Engineering in 2024, and her MS in Environmental Engineering in 2025, both at Stanford University. Beyond her academic passion for waves, Jess loves everything related to the ocean, from surfing to tidepooling to SCUBA diving. In her free time she can be found enjoying the waves, rock climbing, and knitting.
-
Neda Fakhimi
Affiliate, Central Mgmt-Misc AR
BioNeda is an interdisciplinary scientist working at the intersection of bioscience and chemical engineering, with a deep fascination for the function and potential of microbes. Her research focuses on photosynthetic green microalgae, which she finds both visually captivating under the microscope and remarkably capable in their physiological roles. As a postdoctoral scholar in Dr. Arthur Grossman's lab at Carnegie Institution for Science, she investigates the physiological and biochemical functions of NAD kinase isoforms and their roles in regulating central carbon metabolism in photosynthetic systems. Ultimately, she aims to integrate these molecular insights to enable sustainable bioproduction of high-value products, combined with carbon sequestration and waste resource recovery. She also collaborates with a multidisciplinary team of biologists and computer scientists to develop advanced machine learning models for predicting organelle targeting and dual localization of proteins in the green lineage, tools required for advancing fundamental research in this area.
-
Bita Fakhri, MD, MPH
Associate Professor of Medicine (Hematology)
BioDr. Bita Fakhri is an Associate Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, Richter’s syndrome, and other hematologic malignancies.
As a clinical scientist, Dr. Fakhri is dedicated to patient care, trainee education, and the development of novel therapies for individuals with CLL/SLL. She has co-authored numerous publications focusing on CLL, targeted therapies, and cellular therapies in hematologic malignancies.
Dr. Fakhri currently serves as Director of the CLL Clinical Trial Portfolio at Stanford. In addition, she is actively involved in building infrastructure to expand access to clinical trials and promote equity in care for underserved and marginalized populations across the Stanford catchment area. -
Titilola Falasinnu
Assistant Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
BioI am primarily a lupus researcher and identify as a pain scientist and methodologist in this field. Systemic lupus erythematosus (SLE) disproportionately affects women and racial minorities and is the fifth most common cause of death among 15- to 24-year-old Black and Hispanic women in the U.S., highlighting its significant public health impact. More than half of patients with SLE experience chronic pain, often secondary to SLE itself or overlapping conditions (e.g., migraines, low back pain, fibromyalgia), contributing significantly to disability and impaired quality of life. Chronic pain is not merely a symptom but a disease in its own right—one that deserves the same rigorous study and clinical attention as comorbidities like kidney disease and cardiovascular disease in rheumatology. The enormous global burden of chronic pain underscores the urgent need for a clear, standardized definition of pain as a disease, particularly in autoimmune rheumatic diseases where pain can arise from inflammatory, nociplastic, and biopsychosocial mechanisms. Without recognizing pain as a distinct disease entity, its mechanisms remain poorly understood, and effective treatment strategies remain underdeveloped.
I am a co-Principal Investigator of the Pain Intelligence Lab, where our mission is to advance the study of pain as a disease in rheumatology through two primary objectives. First, we develop and validate computational methods that enable clinicians and researchers to leverage electronic health records, administrative claims, and disease registries to study chronic pain as a distinct disease entity in rheumatology. By applying machine learning, natural language processing, and real-world data analysis, we seek to enhance pain phenotyping, classify distinct pain subtypes, and develop predictive models for treatment response. Second, we use a biopsychosocial framework to examine the predictive power of biomarkers and psychosocial measures in rheumatologic pain. By integrating biological, psychological, and social determinants of pain, we aim to conduct rigorous, patient-oriented research that translates targeted assessments into mechanistically informed, personalized treatment approaches for optimized clinical care. Ultimately, my long term career goal is to bridge the gap between research and clinical practice, ensuring that pain management in autoimmune rheumatic diseases is precise, equitable, and optimized for improved patient outcomes. -
Walter Falcon
Senior Fellow, Emeritus, Stanford Woods Institute for the Environment
Current Research and Scholarly Interestsbiotechnology; food security; food and agricultural policy in developing countries
-
Arcadia Falcone
Metadata Coordinator, Metadata Department
Current Role at StanfordMetadata Coordinator and Head, Metadata Design Unit
Metadata Services, Stanford Libraries
